On the public citation graph

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach

0 signed · 106 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.1585openalex-snapshot
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
inferredcites →https://doi.org/10.1002/0471250953.bi0814s24openalex-snapshot
Using AutoDock for Ligand‐Receptor Docking
inferredcites →https://doi.org/10.1007/s11030-018-9840-5openalex-snapshot
Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus
inferredcites →https://doi.org/10.1007/s11030-019-10015-yopenalex-snapshot
Modeling antimalarial and antihuman African trypanosomiasis compounds: a ligand- and structure-based approaches
inferredcites →https://doi.org/10.1007/s13337-020-00585-zopenalex-snapshot
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock
inferredcites →https://doi.org/10.1016/j.antiviral.2018.05.005openalex-snapshot
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
inferredcites →https://doi.org/10.1016/j.ddtec.2004.11.007openalex-snapshot
Lead- and drug-like compounds: the rule-of-five revolution
inferredcites →https://doi.org/10.1016/j.jpha.2020.03.009openalex-snapshot
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
inferredcites →https://doi.org/10.1016/j.jviromet.2019.113806openalex-snapshot
Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design
inferredcites →https://doi.org/10.1016/j.lfs.2020.117592openalex-snapshot
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
inferredcites →https://doi.org/10.1016/j.lfs.2020.117627openalex-snapshot
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s0140-6736(20)30211-7openalex-snapshot
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
inferredcites →https://doi.org/10.1016/s0140-6736(20)30251-8openalex-snapshot
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
inferredcites →https://doi.org/10.1038/cr.1994.1openalex-snapshot
Identification of an k B-like motif at the 5′ upstream region of human lymphotoxin gene
inferredcites →https://doi.org/10.1038/nbt.2786openalex-snapshot
Clinical development success rates for investigational drugs
inferredcites →https://doi.org/10.1038/s41422-020-0282-0openalex-snapshot
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
inferredcites →https://doi.org/10.1038/s41564-020-0695-zopenalex-snapshot
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41579-018-0118-9openalex-snapshot
Origin and evolution of pathogenic coronaviruses
inferredcites →https://doi.org/10.1038/s41598-017-02902-xopenalex-snapshot
A Potential Role of Esophageal Cancer Related Gene-4 for Atrial Fibrillation
inferredcites →https://doi.org/10.1038/srep42717openalex-snapshot
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot
A Novel Coronavirus from Patients with Pneumonia in China, 2019
inferredcites →https://doi.org/10.1056/nejmoa2001191openalex-snapshot
First Case of 2019 Novel Coronavirus in the United States
inferredcites →https://doi.org/10.1080/07391102.1984.10507543openalex-snapshot
Monte Carlo Computer Simulation of the Aqueous Hydration of the Glycine Zwitterion at 25°C
inferredcites →https://doi.org/10.1080/07391102.2008.10507218openalex-snapshot
Ultraconserved Elements Between the Genomes of the PlantsArabidopsis thalianaand Rice
inferredcites →https://doi.org/10.1080/07391102.2020.1753577openalex-snapshot
Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
inferredcites →https://doi.org/10.1080/07391102.2020.1761882openalex-snapshot
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
inferredcites →https://doi.org/10.1093/bioinformatics/btaa645openalex-snapshot
COVID-19 Docking Server: a meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19
inferredcites →https://doi.org/10.1097/cm9.0000000000000744openalex-snapshot
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1136/thorax.2003.012658openalex-snapshot
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
inferredcites →https://doi.org/10.1186/1758-2946-3-33openalex-snapshot
Open Babel: An open chemical toolbox
inferredcites →https://doi.org/10.20944/preprints202002.0242.v2openalex-snapshot
Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
inferredcites →https://doi.org/10.20944/preprints202003.0226.v1openalex-snapshot
Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study
inferredcites →https://doi.org/10.20944/preprints202003.0349.v1openalex-snapshot
In Silico Identification of Potent COVID-19 Main Protease Inhibitors from FDA Approved Antiviral Compounds and Active Phytochemicals through Molecular Docking: A Drug Repurposing Approach
inferredcites →https://doi.org/10.2174/1573406414666181015152511openalex-snapshot
Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study
inferredcites →https://doi.org/10.3389/fgene.2019.00368openalex-snapshot
Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives
inferredcites →https://doi.org/10.3390/v12040445openalex-snapshot
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
inferredcites →https://doi.org/10.3390/v9120364openalex-snapshot
Identification of Alpha and Beta Coronavirus in Wildlife Species in France: Bats, Rodents, Rabbits, and Hedgehogs
inferredcites →https://doi.org/10.5582/bst.2020.01047openalex-snapshot
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/978-3-030-75275-0_99openalex-snapshot
In Silico Analysis of Scopoletin Interaction with Potential SARS-CoV-2 Target
inferred← citeshttps://doi.org/10.1007/978-3-031-81728-1_17openalex-snapshot
Theoretical Analysis of Repurposed Drugs Invoking CDFT-Based Descriptors
inferred← citeshttps://doi.org/10.1007/978-981-16-7857-8_8openalex-snapshot
Identification of Potential Inhibitors Against SARS-CoV-2 3CLpro, PLpro, and RdRP Proteins: An In-Silico Approach
inferred← citeshttps://doi.org/10.1007/s00203-023-03461-8openalex-snapshot
A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants
inferred← citeshttps://doi.org/10.1007/s00894-023-05457-zopenalex-snapshot
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
inferred← citeshttps://doi.org/10.1007/s11030-021-10355-8openalex-snapshot
A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
inferred← citeshttps://doi.org/10.1007/s11030-022-10550-1openalex-snapshot
In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs
inferred← citeshttps://doi.org/10.1007/s40121-021-00447-1openalex-snapshot
Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s40203-023-00165-1openalex-snapshot
Identification of bioactive compounds from Vaccinium vitis-idaea L. (Lingonberry) as inhibitors for treating KRAS-associated cancer: a computational approach
inferred← citeshttps://doi.org/10.1007/s40995-023-01474-yopenalex-snapshot
Computational Insights and Virtual Screening of Repurposed FDA-Approved Drug Against SARS-CoV-2 Protease
inferred← citeshttps://doi.org/10.1016/b978-0-323-91172-6.00007-8openalex-snapshot
Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
inferred← citeshttps://doi.org/10.1016/b978-0-443-18866-4.00009-2openalex-snapshot
Antiviral history and viral targets for antiviral therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-51072-4.00003-xopenalex-snapshot
Traditional uses of Hypericum perforatum in Türkiye and a cross-cultural ethnobotanical assessment with emphasis on biological activities
inferred← citeshttps://doi.org/10.1016/j.bbrep.2021.100982openalex-snapshot
Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
inferred← citeshttps://doi.org/10.1016/j.bbrep.2022.101225openalex-snapshot
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108624openalex-snapshot
Tipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113432openalex-snapshot
Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108853openalex-snapshot
SSHF-DTI: Leveraging structural similarity and hierarchical features through a fusion network for drug-target interaction prediction
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2026.109264openalex-snapshot
Deep learning-based prediction of drug–target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.02.004openalex-snapshot
Drug repurposing against SARS-CoV-2 using computational approaches
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114239openalex-snapshot
Drug repositioning: Progress and challenges in drug discovery for various diseases
inferred← citeshttps://doi.org/10.1016/j.ejps.2021.105771openalex-snapshot
In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach
inferred← citeshttps://doi.org/10.1016/j.eswa.2024.123560openalex-snapshot
A clustering and graph deep learning-based framework for COVID-19 drug repurposing
inferred← citeshttps://doi.org/10.1016/j.gendis.2022.12.019openalex-snapshot
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
inferred← citeshttps://doi.org/10.1016/j.imu.2022.101147openalex-snapshot
Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
inferred← citeshttps://doi.org/10.1016/j.insi.2026.100259openalex-snapshot
Repurposing of FDA-approved antiviral drugs against monkey pox virus: A computational targeting of VP39 methyl transferase
inferred← citeshttps://doi.org/10.1016/j.jiph.2020.12.037openalex-snapshot
Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
inferred← citeshttps://doi.org/10.1016/j.jiph.2021.04.001openalex-snapshot
Nonlinear dynamics for the spread of pathogenesis of COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.jiph.2023.02.014openalex-snapshot
Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines
inferred← citeshttps://doi.org/10.1016/j.jksus.2022.102157openalex-snapshot
Exploring potential anti-chikungunya virus activity of phytocompounds: Computational docking and in vitro studies
inferred← citeshttps://doi.org/10.1016/j.jmgm.2023.108471openalex-snapshot
Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study
inferred← citeshttps://doi.org/10.1016/j.talanta.2022.124127openalex-snapshot
Further quantitative in silico analysis of SARS-CoV-2 S-RBD Omicron BA.4, BA.5, BA.2.75, BQ.1, and BQ.1.1 transmissibility
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c01142openalex-snapshot
HMBVIP: A Novel Hierarchical Multi-Bio-View Intelligent Prediction Networks for Drug–Target Interaction Prediction
inferred← citeshttps://doi.org/10.1021/acs.orglett.4c03736openalex-snapshot
Total Synthesis of Tipranavir Based on Iridium-Catalyzed Asymmetric Allylic Substitution of Dihydropyranone
inferred← citeshttps://doi.org/10.1038/s41392-022-01249-8openalex-snapshot
Small molecules in the treatment of COVID-19
inferred← citeshttps://doi.org/10.1038/s41598-022-24695-4openalex-snapshot
Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations
inferred← citeshttps://doi.org/10.1038/s41598-024-82065-8openalex-snapshot
Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis
inferred← citeshttps://doi.org/10.1080/07391102.2021.1976673openalex-snapshot
Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study
inferred← citeshttps://doi.org/10.1080/17460794.2024.2398953openalex-snapshot
Transitioning from Crisis to Control: Reviewing Antiviral Agents Targeting Pandemic Viruses
inferred← citeshttps://doi.org/10.1093/bib/bbab373openalex-snapshot
Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients
inferred← citeshttps://doi.org/10.1097/qad.0000000000003577openalex-snapshot
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands
inferred← citeshttps://doi.org/10.1142/s0219720025500027openalex-snapshot
SS-DTI: A deep learning method integrating semantic and structural information for drug-target interaction prediction
inferred← citeshttps://doi.org/10.1177/11779322231182050openalex-snapshot
Investigation of Methyl-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxyhydrazide Derivatives as Potential Inhibitors of COVID-19 Main Protease: DFT and Molecular Docking Study
inferred← citeshttps://doi.org/10.1186/s12929-022-00847-6openalex-snapshot
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
inferred← citeshttps://doi.org/10.2147/jep.s524226openalex-snapshot
Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study
inferred← citeshttps://doi.org/10.31276/vjste.63(4).47-54openalex-snapshot
In silico screening of drug inhibitors of SARS-CoV-2RNA-dependent RNA polymerase target
inferred← citeshttps://doi.org/10.33263/lianbs111.29652980openalex-snapshot
Virtual Screening of Potential Drug Molecules Against Covid-19 Targets: A Drug Repurposing Approach
inferred← citeshttps://doi.org/10.3389/fcimb.2024.1353971openalex-snapshot
Natural products as a source of Coronavirus entry inhibitors
inferred← citeshttps://doi.org/10.3389/fcimb.2025.1699057openalex-snapshot
From virtual screening to animal models: chlorhexidine and indinavir as promising anti-Zika drug candidates
inferred← citeshttps://doi.org/10.3389/fphys.2021.710573openalex-snapshot
Effect of Surgical Masks on Cardiopulmonary Function in Healthy Young Subjects: A Crossover Study
inferred← citeshttps://doi.org/10.3390/ijms23074050openalex-snapshot
Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/ijms23147704openalex-snapshot
Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase
inferred← citeshttps://doi.org/10.3390/ijms25105126openalex-snapshot
Prediction of Drug-Target Affinity Using Attention Neural Network
inferred← citeshttps://doi.org/10.3390/ijtm3040032openalex-snapshot
A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
inferred← citeshttps://doi.org/10.3390/microbiolres14030069openalex-snapshot
Natural Products from Red Algal Genus Laurencia as Potential Inhibitors of RdRp and nsp15 Enzymes of SARS-CoV-2: An In Silico Perspective
inferred← citeshttps://doi.org/10.3390/microorganisms9040756openalex-snapshot
A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/pharmaceutics13060795openalex-snapshot
A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies
inferred← citeshttps://doi.org/10.3390/pharmaceutics16091111openalex-snapshot
Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication
inferred← citeshttps://doi.org/10.3390/receptors1010003openalex-snapshot
Novel Cell Receptor System of Eukaryotes Formed by Previously Unknown Nucleic Acid-Based Receptors
inferred← citeshttps://doi.org/10.3390/v16101607openalex-snapshot
Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2
inferred← citeshttps://doi.org/10.34172/bi.2023.24180openalex-snapshot
Platinum(IV) compounds as potential drugs: a quantitative structure-activity relationship study
inferred← citeshttps://doi.org/10.3934/microbiol.2023002openalex-snapshot
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
inferred← citeshttps://doi.org/10.53879/id.60.11.13058openalex-snapshot
CHALLENGES AND OPPORTUNITIES WITH DRUG REPURPOSING: AN EMERGING TECHNIQUE IN DRUGS DISCOVERY
inferred← citeshttps://doi.org/10.54319/jjbs/1505openalex-snapshot
inferred← citeshttps://doi.org/10.54319/jjbs/150503openalex-snapshot
Delavirdine and Dolutegravir as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro): An In-Silico Study
inferred← citeshttps://doi.org/10.6084/m9.figshare.20962344openalex-snapshot
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.